ArticleEuropean radiology2026

Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy.

Jeongin Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.